[{"Assets_0_FY_USD":44981000000.0,"CommonStockDividendsPerShareCashPaid_1_FY_USD":0.52,"CommonStockSharesConverted_0_FY_shares":1100672000.0,"EarningsPerShareBasic_1_FY_USD":-1.58,"EarningsPerShareBasic_4_FY_USD":-0.19,"EarningsPerShareDiluted_1_FY_USD":-1.58,"EarningsPerShareDiluted_4_FY_USD":-0.19,"NetCashProvidedByUsedInOperatingActivitiesConverted_4_FY_USD":5615600000.0,"NetIncomeLossConverted_4_FY_USD":-204100000.0,"NetIncomeLossConverted_1_FY_USD":-1656900000.0,"RevenuesConverted_1_FY_USD":6160700000.0,"RevenuesConverted_4_FY_USD":22871300000.0,"StockholdersEquity_0_FY_USD":11592200000.0,"StockholdersEquityConverted_0_FY_USD":11667900000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_4_FY_shares":1052023000.0,"WeightedAverageNumberOfSharesOutstandingBasic_4_FY_shares":1052023000.0,"Ticker":"LLY","CIK":"59478","name":"LILLY ELI & CO","OfficialName":"Eli Lilly and Company Common Stock","form":"10-K","period":"20171231","fy":"2017.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"282857000000.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"SP500","filed":"20180220"}]